Literature DB >> 11243871

Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli.

J Inokoshi1, H Chiba, S Asanuma, A Takahashi, S Omura, H Tanaka.   

Abstract

Syncytium-inducing variants of the HIV-1 virus are correlated with poor diagnosis and rapid disease progression. We have recently discovered a novel anti-HIV protein, referred to as actinohivin, that inhibits syncytium formation. Here we describe the cloning and sequencing of the gene encoding actinohivin from the actinomycete strain K97-0003, and its expression in Escherichia coli. The actinohivin gene was located on a 0.8-kb BamHI fragment of genomic DNA. The fragment contained an open reading frame of 480 bp, which encoded a protein of 160 amino acids with calculated molecular weight of 17492.7. The N-terminal region was found to be a typical signal peptide of prokaryotes, and actinohivin was located at amino acid positions 46-160. The actinohivin gene could be expressed in E. coli using a pET30Xa/LIC expression vector and the purified recombinant actinohivin was found to inhibit syncytium formation to a similar extent as actinohivin from its natural source. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243871     DOI: 10.1006/bbrc.2001.4496

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Crystallographic study of the interaction of the anti-HIV lectin actinohivin with the α(1-2)mannobiose moiety of gp120 HMTG.

Authors:  Kaoru Suzuki; Naomi Ohbayashi; Jiandong Jiang; Xiaoxue Zhang; M Mominul Hoque; Masaru Tsunoda; Kazutaka Murayama; Haruo Tanaka; Akio Takénaka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-08-30

2.  Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.

Authors:  Bart Hoorelbeke; Dana Huskens; Geoffrey Férir; Katrien O François; Atsushi Takahashi; Kristel Van Laethem; Dominique Schols; Haruo Tanaka; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

3.  HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity.

Authors:  Nobuyuki Matoba; Adam S Husk; Brian W Barnett; Michelle M Pickel; Charles J Arntzen; David C Montefiori; Atsushi Takahashi; Kazunobu Tanno; Satoshi Omura; Huyen Cao; Jason P Mooney; Carl V Hanson; Haruo Tanaka
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

4.  Mechanism by which the lectin actinohivin blocks HIV infection of target cells.

Authors:  Haruo Tanaka; Harumi Chiba; Junji Inokoshi; Atsushi Kuno; Takahiro Sugai; Atsushi Takahashi; Yukishige Ito; Masaru Tsunoda; Kaoru Suzuki; Akio Takénaka; Takeshi Sekiguchi; Hideaki Umeyama; Jun Hirabayashi; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 5.  Antiviral lectins as potential HIV microbicides.

Authors:  Leonardus M I Koharudin; Angela M Gronenborn
Journal:  Curr Opin Virol       Date:  2014-07-08       Impact factor: 7.090

Review 6.  Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections.

Authors:  Milena Mazalovska; J Calvin Kouokam
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

Review 7.  Plant made anti-HIV microbicides--a field of opportunity.

Authors:  Hester C T Lotter-Stark; Edward P Rybicki; Rachel K Chikwamba
Journal:  Biotechnol Adv       Date:  2012-06-28       Impact factor: 14.227

Review 8.  Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.

Authors:  Jan Balzarini
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

Review 9.  Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents.

Authors:  Stephen J Streatfield; Natasha Kushnir; Vidadi Yusibov
Journal:  Plant Biotechnol J       Date:  2015-10       Impact factor: 9.803

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.